ZA884212B - Production of proteins in active forms - Google Patents

Production of proteins in active forms

Info

Publication number
ZA884212B
ZA884212B ZA884212A ZA884212A ZA884212B ZA 884212 B ZA884212 B ZA 884212B ZA 884212 A ZA884212 A ZA 884212A ZA 884212 A ZA884212 A ZA 884212A ZA 884212 B ZA884212 B ZA 884212B
Authority
ZA
South Africa
Prior art keywords
proteins
production
active forms
host cells
source
Prior art date
Application number
ZA884212A
Other languages
English (en)
Inventor
Joseph John Patroni
John Patroni Joseph
Malcolm Roy Brandon
Roy Brandon Malcolm
Original Assignee
Bunge Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge Australia filed Critical Bunge Australia
Publication of ZA884212B publication Critical patent/ZA884212B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA884212A 1987-06-15 1988-06-13 Production of proteins in active forms ZA884212B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (1)

Publication Number Publication Date
ZA884212B true ZA884212B (en) 1989-03-29

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884212A ZA884212B (en) 1987-06-15 1988-06-13 Production of proteins in active forms

Country Status (14)

Country Link
US (1) US4992531A (no)
JP (1) JPS6447389A (no)
KR (1) KR0126767B1 (no)
CN (1) CN1032425C (no)
AT (1) ATE114156T1 (no)
AU (1) AU609824B2 (no)
CA (1) CA1305284C (no)
DE (1) DE3852116T2 (no)
DK (1) DK322188A (no)
ES (1) ES2065911T3 (no)
IE (1) IE66334B1 (no)
NO (1) NO882635L (no)
NZ (1) NZ225032A (no)
ZA (1) ZA884212B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (ja) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 界面活性剤を用いたタンパク質の新規な精製法
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
JP3319812B2 (ja) * 1993-04-05 2002-09-03 井上 聰一 リウマチ判定方法及びリウマチ判定装置
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
ES2361190T3 (es) 1998-08-06 2011-06-14 Mountain View Pharmaceuticals, Inc. Conjugados de peg-oxidasa de urato y su uso.
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
CA2497560A1 (en) * 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
WO2004042003A2 (en) * 2002-11-01 2004-05-21 Promega Corporation Cell lysis compositions, methods of use, apparatus, and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
CZ2007695A3 (cs) 2005-04-11 2008-02-27 Savient Pharmaceuticals, Inc. Variantní formy urátoxidázy a jejich použití
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
WO2006110761A2 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. A variant form of urate oxidase and use thereof
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
EP2272973B1 (en) * 2005-05-31 2015-05-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
HU230758B1 (hu) * 2006-04-12 2018-03-28 Crealta Pharmaceuticals LLC 100% Fehérjék tisztítása kationos felületaktív anyaggal
WO2008076933A2 (en) 2006-12-14 2008-06-26 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
US8288559B2 (en) * 2008-08-18 2012-10-16 Promega Corporation Luminogenic compounds and methods to detect cytochrome P450 3A enzymes
GB0901434D0 (en) * 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
SG176897A1 (en) 2009-06-25 2012-01-30 Savient Pharmaceuticals Inc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
EP2571487B1 (en) 2010-05-21 2023-01-04 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
CN102965317A (zh) * 2012-11-27 2013-03-13 江南大学 一种产牛磺酸菌株的筛选方法及用该菌株发酵法生产牛磺酸
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3172332B1 (en) * 2014-07-22 2020-10-14 Bio-rad Laboratories, Inc. Buffers for use with polymerases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
DE3852116D1 (de) 1994-12-22
ES2065911T3 (es) 1995-03-01
NZ225032A (en) 1991-02-26
CA1305284C (en) 1992-07-14
AU1763288A (en) 1988-12-15
ATE114156T1 (de) 1994-12-15
KR900000380A (ko) 1990-01-30
DE3852116T2 (de) 1995-03-30
CN88103725A (zh) 1988-12-28
AU609824B2 (en) 1991-05-09
IE66334B1 (en) 1995-12-27
DK322188D0 (da) 1988-06-14
NO882635D0 (no) 1988-06-15
JPS6447389A (en) 1989-02-21
KR0126767B1 (ko) 1997-12-29
NO882635L (no) 1988-12-19
CN1032425C (zh) 1996-07-31
DK322188A (da) 1988-12-17
US4992531A (en) 1991-02-12
IE881815L (en) 1988-12-15

Similar Documents

Publication Publication Date Title
ZA884212B (en) Production of proteins in active forms
MY101204A (en) Solubilization of protein aggregates
PH23444A (en) Thrombin preparations
SE8903777D0 (sv) Liposome/doxorubicin, komposition och foerfarande
IL91901A0 (en) Production of liposomes with improved stability during drying
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
AU1141288A (en) Production of proteins in active forms
HU9202435D0 (en) Blood factors produced by a recombinant process, method for expressing said bloode factors and recombinant vaccina viruses utilized in said method
AU7130791A (en) Vectors and compounds for expression of glycosylation mutants of human protein c
MY103362A (en) Production of proteins in active forms
GR851065B (no)
CA2090701A1 (en) Solubilization of proteins in active forms
EP0315118A3 (en) Dna coding for endothelin and use thereof
ZA857166B (en) Process for the extraction of stable camomile extracts which are rich in active agents
MY103305A (en) Productions of proteins in active forms
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
AU5811396A (en) Clothes hanger
GR3003950T3 (no)
IL77152A0 (en) Expression vectors for protein production in e.coli and their production
ITTO930740A1 (it) Metodo per la produzione di tirelle in modo automatico e macchina elementare per eseguirlo.
IT8421028V0 (it) Struttura di macchina agricola, in particolare per trattare argini e simili.